VCYT · Veracyte, Inc.
$55.65
+0.04 (+0.07%)
At close · Jul 28
Market Cap
$4.44B
Shares
79.79M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Marc Stapley | CEO | $7,421,877 |
| John Leite | Chief Commercial Officer | $3,202,810 |
| Rebecca Chambers | CFO | $2,875,554 |
| Annie McGuire | General Counsel | $2,793,104 |
| Phillip G. Febbo | Chief Medical and Scientific Officer | $2,500,972 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Marc Stapley | CEO | $6,816,368 |
| Rebecca Chambers | CFO | $3,645,346 |
| John Leite | Chief Commercial Officer | $3,093,951 |
| Annie McGuire | General Counsel | $3,090,848 |
| Phillip G. Febbo | Chief Medical and Scientific Officer | $2,789,661 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Marc Stapley | CEO | $7,184,634 |
| Phillip G. Febbo | Chief Medical and Scientific Officer | $3,787,041 |
| Rebecca Chambers | CFO | $2,778,584 |
| Annie McGuire | General Counsel | $2,481,118 |
| John Leite | Chief Commercial Officer | $1,924,469 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Marc Stapley | CEO | $4,935,422 |
| Tina Nova | General Manager, Decipher & Afirma Franchise | $4,598,529 |
| Giulia Kennedy | SVP, Research & Development | $4,533,563 |
| Rebecca Chambers | CFO | $3,322,756 |
| Annie McGuire | General Counsel | $2,447,055 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Marc Stapley | CEO | $5,741,940 |
| Bonnie Anderson | Chairman & Chief Executive Officer | $4,518,093 |
| Rebecca Chambers | CFO | $3,382,037 |
| Keith Kennedy | CFO | $2,654,814 |
| Giulia Kennedy | SVP, Research & Development | $2,636,699 |
| Jane Alley | Vice President, Accounting | $1,288,216 |
| James Erlinger III | General Counsel | $1,215,753 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Bonnie Anderson | Chairman & Chief Executive Officer | $4,571,345 |
| James Erlinger III | General Counsel | $3,118,425 |
| Keith Kennedy | CFO | $2,025,917 |
| Giulia Kennedy | SVP, Research & Development | $1,870,560 |
| John Hanna | President & CEO | $1,785,853 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Bonnie Anderson | Chairman & Chief Executive Officer | $4,161,963 |
| Keith Kennedy | CFO | $2,773,676 |
| Giulia Kennedy | SVP, Research & Development | $2,124,410 |
| John Hanna | President & CEO | $2,030,010 |
| Christopher Hall | President and Chief Operating Officer | $700,674 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Bonnie Anderson | CEO | $2,831,240 |
| Christopher Hall | President and Chief Operating Officer | $1,578,415 |
| Keith Kennedy | CFO | $1,466,109 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Bonnie Anderson | CEO | $2,213,128 |
| Christopher Hall | President and Chief Operating Officer | $1,084,004 |
| Keith Kennedy | CFO | $792,685 |
Key facts
CIK
1384101
CUSIP
92337F107
13F (30d)
67 filings
67 filers
Visit website
Investor relations